These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 4334089

  • 1. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB, Boldrey EB, Enot KJ.
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract] [Full Text] [Related]

  • 2. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD, Hurwitz BS.
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract] [Full Text] [Related]

  • 3. Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.
    Rosenblum ML, Reynolds AF, Smith KA, Rumack BH, Walker MD.
    J Neurosurg; 1973 Sep; 39(3):306-14. PubMed ID: 4354763
    [No Abstract] [Full Text] [Related]

  • 4. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR.
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract] [Full Text] [Related]

  • 5. Scintiphotographic evaluation of response of brain neoplasms to systemic chemotherapy.
    Handel SF, Powell MR, Wilson CB, Enot KJ.
    J Nucl Med; 1971 Jun; 12(6):292-6. PubMed ID: 4325620
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of malignant brain tumors with nitrosoureas.
    Hansen HH, Muggia FM.
    Cancer Chemother Rep; 1971 Apr; 55(2):99-100. PubMed ID: 4330275
    [No Abstract] [Full Text] [Related]

  • 7. [Chemotherapy of brain neoplasms in children].
    Jacobi H.
    Z Allgemeinmed; 1974 Sep 10; 50(25):1092-6. PubMed ID: 4373943
    [No Abstract] [Full Text] [Related]

  • 8. The uptake, distribution, and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the murine glioma.
    Levin VA, Shapiro WR, Clancy TP, Oliverio VT.
    Cancer Res; 1970 Oct 10; 30(10):2451-5. PubMed ID: 5474173
    [No Abstract] [Full Text] [Related]

  • 9. Lack of correlation between clinical and angiographic findings in patients with brain tumors under BCNU chemotherapy.
    Koo AH, Fewer D, Wilson CB, Newton TH.
    J Neurosurg; 1972 Jul 10; 37(1):9-14. PubMed ID: 4338690
    [No Abstract] [Full Text] [Related]

  • 10. [Chemotherapeutic combinations of mutually potentiating drugs. 3-Application to primary tumors of the central nervous system].
    Pouillart P, Schwarzenberg L, Amiel JL, Mathé G, Huguenin P, Morin P, Baron A, Laparre Ch, Parrot R.
    Nouv Presse Med; 1975 Mar 08; 4(10):721-4. PubMed ID: 165461
    [Abstract] [Full Text] [Related]

  • 11. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
    Shapiro WR, Ausman JI, Rall DP.
    Cancer Res; 1970 Sep 08; 30(9):2401-13. PubMed ID: 5475484
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL.
    Vopr Onkol; 2007 Sep 08; 53(6):724-9. PubMed ID: 18416147
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
    Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG.
    Cancer Chemother Rep; 1971 Jun 08; 55(3):303-7. PubMed ID: 5115851
    [No Abstract] [Full Text] [Related]

  • 14. Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma.
    Thomson JM, Maruyama Y, Schwartz S, Hahn E.
    Radiology; 1971 Oct 08; 101(1):187-94. PubMed ID: 4329540
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB, Falkson HC, Falkson G.
    Cancer Chemother Rep; 1970 Oct 08; 54(5):347-59. PubMed ID: 5514624
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC, DeConti RC, Hubbard SP.
    Cancer Chemother Rep; 1971 Dec 08; 55(5):599-606. PubMed ID: 4334161
    [No Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy in malignant melanoma.
    Moon JH.
    Cancer; 1970 Aug 08; 26(2):468-73. PubMed ID: 5451222
    [No Abstract] [Full Text] [Related]

  • 20. Phase I study of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466) in adults with solid tumors.
    Stewart DJ, Benjamin RS, Leavens M, Valdivieso M, Burgess MA, Bodey GP.
    Cancer Res; 1980 Oct 08; 40(10):3750-4. PubMed ID: 6254639
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.